Agricultural sciences firm FMC Q3 revenue misses estimates hurt by one-time commercial actions on India business

FMC

29/10/2025 20:56

Overview

FMC Q3 revenue declines 49% yr/yr, missing analyst expectations, per LSEG data

Adjusted EPS for Q3 beats analyst expectations, rising 30% yr/yr

Company reduces quarterly dividend to $0.08 per share to prioritize debt reduction

Outlook

FMC lowers full-year revenue outlook to $3.92 bln to $4.02 bln

Company expects Q4 revenue, excluding India, to be $1.12 bln to $1.22 bln

FMC forecasts Q4 adjusted EPS to be $1.14 to $1.36

Result Drivers

INDIA ACTIONS - Significant one-time commercial actions in India led to a 49% revenue decline, positioning the business for sale

COMPETITIVE PRESSURE - Increased generic competition in Latin America and Asia led to lower pricing and volume

NEW ACTIVE INGREDIENTS - New active ingredients nearly doubled in Q3, contributing positively to growth portfolio

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q3 Revenue
Miss
$542 mln
$1.07 bln (14 Analysts)
Q3 Adjusted EPS
Beat
$0.89
$0.87 (17 Analysts)
Q3 Net Income
-$569 mln
Q3 Adjusted EBITDA
Beat
$236 mln
$230.30 mln (13 Analysts)

Analyst Coverage

The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 9 "strong buy" or "buy", 11 "hold" and 1 "sell" or "strong sell"

The average consensus recommendation for the agricultural chemicals peer group is "buy."

Wall Street's median 12-month price target for FMC Corp is $41.50, about 26.4% above its October 28 closing price of $30.54

The stock recently traded at 8 times the next 12-month earnings vs. a P/E of 11 three months ago

Press Release: ID:nPnbb57GPa

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)